Finding protein markers that indicate risk for abdominal aortic aneurysm
Identifying Proteomics Risk Markers for Abdominal Aortic Aneurysm
This study is looking for certain proteins in the blood that might help predict if someone is at risk of developing an abdominal aortic aneurysm (AAA), which is a serious health issue, and it's designed for anyone interested in understanding more about their health risks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10846849 on NIH RePORTER |
What this research studies
This research aims to identify specific protein markers in the blood that can indicate a person's risk of developing abdominal aortic aneurysm (AAA), a serious condition that can lead to life-threatening complications. By analyzing a large dataset of blood samples from participants over many years, the study will look for patterns and markers that correlate with the development of AAA. The research will utilize advanced proteomic techniques to assess thousands of proteins and will also replicate findings in other population studies to ensure accuracy and reliability.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those with risk factors for abdominal aortic aneurysm, such as a family history of the condition or other cardiovascular issues.
Not a fit: Patients who are younger and do not have any risk factors for abdominal aortic aneurysm may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better screening methods and risk assessment for abdominal aortic aneurysm, potentially saving lives through earlier intervention.
How similar studies have performed: Previous research has successfully identified epidemiological risk factors for AAA, suggesting that this proteomic approach may also yield significant findings.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Tang, Weihong — University of Minnesota
- Study coordinator: Tang, Weihong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.